328 related articles for article (PubMed ID: 29784043)
1. Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.
Zhou JD; Zhang LC; Zhang TJ; Gu Y; Wu DH; Zhang W; Ma JC; Wen XM; Guo H; Lin J; Qian J
J Transl Med; 2018 May; 16(1):135. PubMed ID: 29784043
[TBL] [Abstract][Full Text] [Related]
2. Low expression of microRNA-340 confers adverse clinical outcome in patients with acute myeloid leukemia.
Wang Q; Feng T; Xu J; Miao MH; Ji XQ; Zhu H; Shao XJ
J Cell Physiol; 2019 Apr; 234(4):4200-4205. PubMed ID: 30171606
[TBL] [Abstract][Full Text] [Related]
3. High bone marrow miR-19b level predicts poor prognosis and disease recurrence in de novo acute myeloid leukemia.
Zhang TJ; Lin J; Zhou JD; Li XX; Zhang W; Guo H; Xu ZJ; Yan Y; Ma JC; Qian J
Gene; 2018 Jan; 640():79-85. PubMed ID: 29032147
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of miR-216b: Prognostic and predictive value in acute myeloid leukemia.
Zhang TJ; Wu DH; Zhou JD; Li XX; Zhang W; Guo H; Ma JC; Deng ZQ; Lin J; Qian J
J Cell Physiol; 2018 Apr; 233(4):3274-3281. PubMed ID: 28884855
[TBL] [Abstract][Full Text] [Related]
5. Down-Regulation of miR-186 Correlates with Poor Survival in de novo Acute Myeloid Leukemia.
Zhang TJ; Wang YX; Yang DQ; Yao DM; Yang L; Zhou JD; Deng ZQ; Wen XM; Guo H; Ma JC; Lin J; Qian J
Clin Lab; 2016; 62(1-2):113-20. PubMed ID: 27012040
[TBL] [Abstract][Full Text] [Related]
6. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
[TBL] [Abstract][Full Text] [Related]
7. Downregulated miR-217 expression predicts a poor outcome in acute myeloid leukemia.
Yan J; Wu G; Chen J; Xiong L; Chen G; Li P
Cancer Biomark; 2018; 22(1):73-78. PubMed ID: 29439315
[TBL] [Abstract][Full Text] [Related]
8. Expression of serum miR-200a, miR-200b, and miR-200c as candidate biomarkers in epithelial ovarian cancer and their association with clinicopathological features.
Zuberi M; Mir R; Das J; Ahmad I; Javid J; Yadav P; Masroor M; Ahmad S; Ray PC; Saxena A
Clin Transl Oncol; 2015 Oct; 17(10):779-87. PubMed ID: 26063644
[TBL] [Abstract][Full Text] [Related]
9. Low expression of circulating microRNA-328 is associated with poor prognosis in patients with acute myeloid leukemia.
Liu L; Chen R; Zhang Y; Fan W; Xiao F; Yan X
Diagn Pathol; 2015 Jul; 10():109. PubMed ID: 26185105
[TBL] [Abstract][Full Text] [Related]
10. Re-expression of miR-200s in claudin-low mammary tumor cells alters cell shape and reduces proliferation and invasion potentially through modulating other miRNAs and SUZ12 regulated genes.
Simpson K; Conquer-van Heumen G; Watson KL; Roth M; Martin CJ; Moorehead RA
Cancer Cell Int; 2021 Feb; 21(1):89. PubMed ID: 33541373
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of serum MicroRNA-203 in patients with acute myeloid leukemia.
Guo Y
Bioengineered; 2019 Dec; 10(1):345-352. PubMed ID: 31411110
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of miR-96 in patients with acute myeloid leukemia.
Zhao J; Lu Q; Zhu J; Fu J; Chen YX
Diagn Pathol; 2014 Mar; 9():76. PubMed ID: 24678958
[TBL] [Abstract][Full Text] [Related]
13. Lower expression of bone marrow miR-122 is an independent risk factor for overall survival in cytogenetically normal acute myeloid leukemia.
Zhang TJ; Qian Z; Wen XM; Zhou JD; Li XX; Xu ZJ; Ma JC; Zhang ZH; Lin J; Qian J
Pathol Res Pract; 2018 Jun; 214(6):896-901. PubMed ID: 29627222
[TBL] [Abstract][Full Text] [Related]
14. Methylation-independent CHFR expression is a potential biomarker affecting prognosis in acute myeloid leukemia.
Zhou JD; Zhang TJ; Li XX; Ma JC; Guo H; Wen XM; Yao DM; Zhang W; Lin J; Qian J
J Cell Physiol; 2018 Jun; 233(6):4707-4714. PubMed ID: 29115660
[TBL] [Abstract][Full Text] [Related]
15. Low Expression of FUS1 Is Negatively Correlated with miR-378 and May Predict Adverse Prognoses in Acute Myeloid Leukemia.
Tang X; Zhou J; Zhang J; Zhou LY; Zhai LL; Vanessa ME; Yi J; Yi YY; Lin J; Deng ZQ
Acta Haematol; 2018; 139(2):89-95. PubMed ID: 29393096
[TBL] [Abstract][Full Text] [Related]
16. Transgenic overexpression of the miR-200b/200a/429 cluster inhibits mammary tumor initiation.
Watson KL; Yi R; Moorehead RA
Transl Oncol; 2021 Dec; 14(12):101228. PubMed ID: 34562686
[TBL] [Abstract][Full Text] [Related]
17. Identification of let-7a-2-3p or/and miR-188-5p as prognostic biomarkers in cytogenetically normal acute myeloid leukemia.
Jinlong S; Lin F; Yonghui L; Li Y; Weidong W
PLoS One; 2015; 10(2):e0118099. PubMed ID: 25646775
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of miR-210 is Associated with Poor Prognosis of Acute Myeloid Leukemia.
Tang X; Chen L; Yan X; Li Y; Xiong Y; Zhou X
Med Sci Monit; 2015 Nov; 21():3427-33. PubMed ID: 26549593
[TBL] [Abstract][Full Text] [Related]
19. Low expression of microRNA-204 (miR-204) is associated with poor clinical outcome of acute myeloid leukemia (AML) patients.
Butrym A; Rybka J; Baczyńska D; Tukiendorf A; Kuliczkowski K; Mazur G
J Exp Clin Cancer Res; 2015 Jul; 34(1):68. PubMed ID: 26126974
[TBL] [Abstract][Full Text] [Related]
20. PIM-1 mRNA expression is a potential prognostic biomarker in acute myeloid leukemia.
Cheng H; Huang C; Xu X; Hu X; Gong S; Tang G; Song X; Zhang W; Wang J; Chen L; Yang J
J Transl Med; 2017 Aug; 15(1):179. PubMed ID: 28851457
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
